New Jersey S 1053: Prohibits substitution of prescribed epilepsy drugs by pharmacists without prior notification to and written consent of physician and patient.

Status: Introduced in the Senate, Referred to Senate Health, Human Services and Senior Citizens Committee (as of 2022-01-31)

State: New Jersey · Session: 220 · Bill: S 1053

Subjects: PHARMACEUTIC

Sponsors: Vitale, Joseph F.

View New Jersey S 1053 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.